Guardant Health
$2.72 B
Share price
Change (1 day)
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: $2.72 Billion

As of March 2023 Guardant Health has a market cap of $2.72 Billion. This makes Guardant Health the world's 3282th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2023

End of year Market Cap

Year Market cap Change
2023$2.72 B-2.17%
2022$2.78 B-72.6%
2021$10.16 B-21.09%
2020$12.88 B75.59%
2019$7.33 B127.64%
2018$3.22 B

End of Day market cap according to different sources

On Mar 21st, 2023 the market cap of Guardant Health was reported to be:

$2.71 Billion
by Yahoo Finance
$2.72 Billion
by CompaniesMarketCap
$2.71 Billion
by Nasdaq
$2.72 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$4.08 B 49.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.41 B 135.36%๐Ÿ‡บ๐Ÿ‡ธ USA